Prime Gene Therapeutics Co., Ltd.
Quick facts
Phase 3 pipeline
- PG-011Gel · Genetics
PG-011Gel is a gene therapy that targets the underlying cause of certain diseases. - Placebo (twice daily)
Placebo produces no pharmacological effect and serves as an inert control in clinical trials.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: